Back

Contemporary trends and factors associated with use of subcutaneous versus transvenous implantable cardioverter-defibrillator therapy

EP Europace Journal

21 June 2024
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Device Therapy

Contributors

Islam Shatla
Islam Shatla

Author

University of Kansas Medical Center Kansas City , United States of America

Nikhil Mehta
Nikhil Mehta

Author

Kevin F Kennedy
Kevin F Kennedy

Author

Ahmed Elkaryoni
Ahmed Elkaryoni

Author

Alan P Wimmer
Alan P Wimmer

Author

You may be interested in
thumbnail
Congress Presentation
Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.
24 April 2021
thumbnail
Congress Session
Navigating through heart failure device therapies
18 May 2025
thumbnail
Congress Session
Implantable cardioverter-defibrillator therapy in contemporary practice: outcomes, predictors, and expanding indications
29 August 2026
thumbnail
Congress Presentation
Is primary prevention implantable cardioverter defibrillator implantation still warranted in the era of modern heart failure therapy? - a retrospective real-world cohort analysis
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources